5 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin Desogestrel and ethinylestradiol fixed dose combination, Follitropin alfa/lutropin alfa - Fertility | Phase 1 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 24 | 2025-11-24 | 2026-03-18 |
| Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product Desogestrel 0.075 MG - Bioequivalence | Phase 1 | Completed | Laboratorios Andromaco S.A. | 30 | 2020-01-11 | 2020-06-09 |
| Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/ Cerazette - Biological Availability | Phase 1 | Completed | Bayer | 68 | 2017-11-29 | 2020-04-15 |
| A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives Desogestrel/ethinyl estradiol and ethinyl estradiol, 28-day drospirenone oral contraceptive, 28-day levonorgestrel oral contraceptive - Follicle Development, Ovarian Follicle | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 206 | 2011-01-31 | 2021-12-08 |
| Antagonist/Letrozole in Poor Responders letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation | Phase 1 / Phase 2 | Completed | Yazd Research & Clinical Center for Infertility | 120 | 2008-06-01 | 2013-12-23 |
Infertility (1)
Bayer (1) · Laboratorios Andromaco S.A. (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · Yazd Research & Clinical Center for Infertility (1)
Chile (1) · Germany (1) · Iran (1) · United Kingdom (1) · United States (1)
2017 (1)